BBeyond News Search Beyond News…

Loading…

BioNTech

BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.

Recent news mentioning BioNTech

2026-08-28 — BioNTech Tumbles 8% as Colorectal Cancer Vaccine Trial Fails, Moderna Drops 6%, Pfizer Holds Flat
2026-08-27 — BioNTech (BNTX) Rallied on Moderna’s Win. Does a Competitor’s Success Validate its Oncology Pipeline?
2026-08-26 — Moderna Drops 7% Despite a Fresh Wolfe Research Upgrade, BioNTech Slips
2026-08-25 — Moderna Rallies 11%, BioNTech Ticks Up: Is the mRNA Trade Down to One Name?
2026-08-24 — Moderna Sinks 7% as Traders Book Profits on a 392% Year-to-Date Surge; BioNTech Drops 4%, Merck Slips
2026-08-24 — BioNTech Moved Higher as the Broader Biotech Sector Hit a Post-Pandemic Peak, but BNTX Stock Needs Stronger Fundamentals to Keep Climbing
2026-08-20 — Moderna Sinks 18% After 177% Cancer Vaccine Rally, BioNTech Falls 4%, Merck Slips
2026-08-20 — BioNTech Stock Surges 22% on Moderna Cancer Vaccine Win. Why the Gains Could Fade.
2026-08-14 — BioNTech’s oncology pivot comes with a new CEO
2026-08-13 — BioNTech Just Named a New CEO. Here's What Guido Oelkers' Appointment Means for the Stock.
2026-08-11 — Pfizer Inc. (PFE) vs. BioNTech SE (BNTX): Which Pharma Giant Is Better Positioned for the Post-COVID Era?
2026-08-04 — BioNTech Q2 Earnings Call Highlights

Appears alongside

See BioNTech's full profile, network and analytical read on Beyond →